Population-based study of ovarian cancer in Côte d'Or: Prognostic factors and trends in relative survival rates over the last 20 years

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Hamidou, Zeinab ^a,b   Causeret, Sylvain ^a   Dabakuyo, Tienhan S ^a,b   Gentil, Julie ^a,b   Arnould, Laurent ^a   Roignot, Patrick ^c   Altwegg, Thierry ^d   Poillot, Marie Laure ^a   Bonnetain, Franck ^a,b   Arveux, Patrick ^a,b  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Centre de Pathologie   (France)

^d Centre Radiotherapie du Parc   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FRANCE; GYNECOLOGY; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; POPULATION RESEARCH; PROGNOSIS; RURAL AREA; SCHOOL CHILD; SURVIVAL RATE; TREND STUDY; TUMOR CLASSIFICATION; URBAN AREA; MIDDLE AGED; MORTALITY; ONCOLOGY; OVARY TUMOR; REGISTER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FRANCE; HUMANS; MEDICAL ONCOLOGY; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78149235036     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-622     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108. 10.3322/canjclin.55.2.74, 15761078.
2. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008, 56:159-75. 10.1016/j.respe.2008.03.117, 18547762.
3. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 2003, 189:1120-7. 10.1067/S0002-9378(03)00579-9, 14586365.
4. Venesmaa P. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990. Obstet Gynecol 1994, 84:8-11.
5. Engel J, Eckel R, Schubert-Fritschle G, Kerr J, Kuhn W, Diebold J, Kimmig R, Rehbock J, Hölzel. Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate. Eur J Cancer 2002, 38:2435-45. 10.1016/S0959-8049(02)00495-1, 12460789.
6. Chan JK, Loizzi V, Lin YG, Osann K, Brewster WR, DiSaia PJ. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important?. Obstet Gynecol 2003, 102:156-61. 10.1016/S0029-7844(03)00399-5, 12850623.
7. Winter WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, Markman M, Armstrong DK, Muggia F, McGuire WP. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 2007, 25:3621-7. 10.1200/JCO.2006.10.2517, 17704411.
8. Hölscher G, Anthuber C, Bastert G, Burges A, Mayr D, Oberlechner E, Schubert-Fritschle G, Sinz S, Sommer H, Schmalfeldt B, Engel J. Improvement of survival in sex cord stromal tumors - an observational study with more than 25 years follow-up. Acta Obstet Gynecol Scand 2009, 88:440-8. 10.1080/00016340902741208, 19191075.
9. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004, 23:51-64. 10.1002/sim.1597, 14695639.
10. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996, 17:343-6. 10.1016/0197-2456(96)00075-X, 8889347.
11. Akeson M, Jakobsen AM, Zetterqvist BM, Holmberg E, Brännström M, Horvath G. A population-based 5-year cohort study including all cases of epithelial ovarian cancer in western Sweden: 10-year survival and prognostic factors. Int J Gynecol Cancer 2009, 19:116-23.
12. Gondos A, Holleczek B, Arndt V, Stegmaier C, Ziegler H, Brenner H. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?. Ann Oncol 2007, 18:1253-9. 10.1093/annonc/mdm126, 17470450.
13. Tingulstad S, Skjeldestad FE, Halvorsen TB, Hagen B. Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 2003, 101:885-91. 10.1016/S0029-7844(03)00123-6, 12738145.
14. Pectasides D, Papaxoinis G, Fountzilas G, Aravantinos G, Bamias A, Pavlidis N, Kalofonos HP, Timotheadou E, Samantas E, Briasoulis E, Skarlos DV, Economopoulos T, et al. Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG). Anticancer Res 2009, 29:745-51.
15. Tracey EA, Roder DM, Francis J, Zorbas HM, Hacker NF, Bishop JF. Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control. Int J Gynecol Cancer 2009, 19:591-9.
16. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol 2008, 109:370-6. 10.1016/j.ygyno.2008.02.006, 18395777.
17. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol 2003, 21:1530-5. 10.1200/JCO.2003.08.065, 12697877.
18. Maas HA, Kruitwagen RF, Lemmens VE, Goey SH, Janssen-Heijnen ML. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol 2005, 97:104-9. 10.1016/j.ygyno.2004.12.026, 15790445.
19. Akeson M, Zetterqvist BM, Dahllöf K, Brännström M, Horvath G. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up. Acta Obstet Gynecol Scand 2008, 87:1343-52. 10.1080/00016340802495491, 18951208.
20. Muñoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol 1997, 15:3408-15.
21. Panprom P, Lertkhachonsuk R. Outcome of ovarian cancer patients who underwent incomplete surgical staging. J Med Assoc Thai 2008, 91:1323-30.
22. Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K. Patterns and progress in ovarian cancer over 14 years. Obstet Gynecol 2006, 108:521-8. 10.1097/01.AOG.0000231680.58221.a7, 16946210.
23. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002, 20:1248-59. 10.1200/JCO.20.5.1248, 11870167.
24. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Seow A, Lee HP. Population-based cancer survival in Singapore, 1968 to 1992: an overview. Int J Cancer 2001, 3:142-7.